These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10149980)

  • 1. Biocompatibility issues in hemodialysis.
    Vanholder R
    Clin Mater; 1992; 10(1-2):87-133. PubMed ID: 10149980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of dialysis membranes in infection.
    Vanholder R; Van Loo A; Dhondt AM; Ringoir S
    Nephrol Dial Transplant; 1996; 11 Suppl 2():101-3. PubMed ID: 8804006
    [No Abstract]   [Full Text] [Related]  

  • 3. Biocompatibility of dialysis membranes.
    Salem M; Ivanovich P; Mujais S
    Contrib Nephrol; 1993; 103():55-64. PubMed ID: 8354063
    [No Abstract]   [Full Text] [Related]  

  • 4. Biocompatible characteristics of high-performance membranes.
    Uda S; Mizobuchi M; Akizawa T
    Contrib Nephrol; 2011; 173():23-29. PubMed ID: 21865772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between biocompatibility and neutrophil function in hemodialysis patients.
    Vanholder R
    Adv Ren Replace Ther; 1996 Oct; 3(4):312-4. PubMed ID: 8914695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time PCR as a new in vitro biocompatibility method to measure leukocyte response to surface contact in dialysis filter devices.
    Brodbeck K; Neubauer M; Schnitzer S; Dietrich R; Hulko M; Krause B
    Int J Artif Organs; 2013 Apr; 36(4):240-50. PubMed ID: 23504810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility of dialysis membrane.
    Kes P
    Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis].
    Canaud B; Mion C
    Nephrologie; 1995; 16(1):129-35. PubMed ID: 7700413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic polyneuropathy: different effects of hemodialysis and continuous ambulatory peritoneal dialysis.
    Tegnér R; Lindholm B
    Acta Med Scand; 1985; 218(4):409-16. PubMed ID: 4083083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phagocyte function in uremic patients].
    Ringoir S; Vanholder R
    Verh K Acad Geneeskd Belg; 1991; 53(3):189-201; discussion 201-3. PubMed ID: 1927026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baclofen neurotoxicity in uremic patients: is continuous ambulatory peritoneal dialysis less effective than intermittent hemodialysis?
    Chen YC; Chang CT; Fang JT; Huang CC
    Ren Fail; 2003 Mar; 25(2):297-305. PubMed ID: 12739836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune status of the uremic patient: hemodialysis vs CAPD.
    Schollmeyer P; Bozkurt F
    Clin Nephrol; 1988; 30 Suppl 1():S37-40. PubMed ID: 3052959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of the uremic diabetic.
    Shyh TP; Beyer MM; Friedman EA
    Nephron; 1985; 40(2):129-38. PubMed ID: 3889674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are biocompatible membranes superior for hemodialysis therapy?
    van Ypersele de Strihou C
    Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic pruritus in patients on hemodialysis or continuous ambulatory peritoneal dialysis (CAPD). The role of plasma histamine and skin mast cells.
    Mettang T; Fritz P; Weber J; Machleidt C; Hübel E; Kuhlmann U
    Clin Nephrol; 1990 Sep; 34(3):136-41. PubMed ID: 1699691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical sequelae of complement activation in hemodialysis.
    Hakim RM
    Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.